Patents by Inventor Ivo Gomperts Boneca

Ivo Gomperts Boneca has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-, pro- or synbiotics) for improving the efficacy of a cancer treatment
    Patent number: 11344586
    Abstract: The present invention provides methods for determining if a patient is likely to benefit from a cancer treatment, by determining if said patient has a gut dysbiosis with an over representation of certain bacterial species. The present invention also provides probiotic strains to improve the efficacy of a cancer treatment, especially chemotherapy, in patients in need thereof.
    Type: Grant
    Filed: April 21, 2020
    Date of Patent: May 31, 2022
    Assignees: INSTITUT GUSTAVE ROUSSY, UNIVERSITE PARIS-SACLAY, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT
    Inventors: Laurence Zitvogel, Ivo Gomperts Boneca, Patricia Lepage, Sophie Viaud, Romain Daillere
  • MICROBIOTA COMPOSITION, AS A MARKER OF RESPONSIVENESS TO CHEMOTHERAPY, AND USE OF MICROBIAL MODULATORS (PRE-, PRO- OR SYNBIOTICS) FOR IMPROVING THE EFFICACY OF A CANCER TREATMENT
    Publication number: 20200360449
    Abstract: The present invention provides methods for determining if a patient is likely to benefit from a cancer treatment, by determining if said patient has a gut dysbiosis with an over representation of certain bacterial species. The present invention also provides probiotic strains to improve the efficacy of a cancer treatment, especially chemotherapy, in patients in need thereof.
    Type: Application
    Filed: April 21, 2020
    Publication date: November 19, 2020
    Inventors: Laurence ZITVOGEL, Ivo GOMPERTS BONECA, Patricia LEPAGE, Sophie VIAUD, Romain DAILLERE
  • Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-, pro- or synbiotics) for improving the efficacy of a cancer treatment
    Patent number: 10646521
    Abstract: The present invention provides methods for determining if a patient is likely to benefit from a cancer treatment, by determining if said patient has a gut dysbiosis with an over representation of certain bacterial species. The present invention also provides probiotic strains to improve the efficacy of a cancer treatment, especially chemotherapy, in patients in need thereof.
    Type: Grant
    Filed: November 21, 2014
    Date of Patent: May 12, 2020
    Assignees: INSTITUT GUSTAVE ROUSSY, UNIVERSITÉ PARIS—SACLAY, INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE, INSTITUT DE LA RECHERCHE AGRONOMIQUE
    Inventors: Laurence Zitvogel, Ivo Gomperts Boneca, Patricia Lepage, Sophie Viaud, Romain Daillere
  • MICROBIOTA COMPOSITION, AS A MARKER OF RESPONSIVENESS TO CHEMOTHERAPY, AND USE OF MICROBIAL MODULATORS (PRE-, PRO- OR SYNBIOTICS) FOR IMPROVING THE EFFICACY OF A CANCER TREATMENT
    Publication number: 20160303172
    Abstract: The present invention provides methods for determining if a patient is likely to benefit from a cancer treatment, by determining if said patient has a gut dysbiosis with an over representation of certain bacterial species. The present invention also provides probiotic strains to improve the efficacy of a cancer treatment, especially chemotherapy, in patients in need thereof.
    Type: Application
    Filed: November 21, 2014
    Publication date: October 20, 2016
    Inventors: Laurence ZITVOGEL, Ivo GOMPERTS BONECA, Patricia LEPAGE, Sophie VIAUD, Romain DAILLERE
  • Method for inducing lymphoid tissue and modulating intestinal homeostasis
    Patent number: 9050320
    Abstract: Methods and products for modulating the lymphoid system, especially intestinal homeostasis between intestinal lymphoid tissues and gut flora using ligands for NOD1 and/or CCR6.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: June 9, 2015
    Assignee: INSTITUT PASTEUR
    Inventors: Gerard Eberl, Djahida Bouskra, Ivo Gomperts Boneca, Christophe Brezillon
  • METHOD FOR INDUCING LYMPHOID TISSUE AND MODULATING INTESTINAL HOMEOSTASIS
    Publication number: 20130315922
    Abstract: Methods and products for modulating the lymphoid system, especially intestinal homeostasis between intestinal lymphoid tissues and gut flora using ligands for NOD1 and/or CCR6.
    Type: Application
    Filed: March 15, 2013
    Publication date: November 28, 2013
    Inventors: Gerard EBERL, Djahida Bouskra, Ivo Gomperts Boneca, Christophe Brezillon
  • Method for inducing lymphoid tissue and modulating intestinal homeostasis
    Patent number: 8425920
    Abstract: Methods and products for modulating the lymphoid system, especially intestinal homeostasis between intestinal lymphoid tissues and gut flora using ligands for NOD1 and/or CCR6.
    Type: Grant
    Filed: April 27, 2009
    Date of Patent: April 23, 2013
    Assignee: Institut Pasteur
    Inventors: Gerard Eberl, Djahida Bouskra, Ivo Gomperts Boneca, Christophe Brezillon
  • METHOD FOR INDUCING LYMPHOID TISSUE AND MODULATING INTESTINAL HOMEOSTASIS
    Publication number: 20100272646
    Abstract: Methods and products for modulating the lymphoid system, especially intestinal homeostasis between intestinal lymphoid tissues and gut flora using ligands for NOD1 and/or CCR6.
    Type: Application
    Filed: April 27, 2009
    Publication date: October 28, 2010
    Inventors: Gerard EBERL, Djahida Bouskra, Ivo Gomperts Boneca, Christophe Brezillon